FDA Drug Application (050627) for RIFADIN by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number050627
Product Number001
FormINJECTABLE;INJECTION
Dosage600MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameRIFADIN
Active IngredientRIFAMPIN

Active IngredientCount
List of drugs with Active Ingredient RIFAMPIN6


Back to FDA Applications sponsored by SANOFI AVENTIS US